Partha Basu, Head of the Early Detection, Prevention and Infections Branch at International Agency for Research on Cancer (IARC), shared a post by International Papillomavirus Society – IPVS on LinkedIn:
“Thrilled to see IPVS selecting our study in India showing high agreement between self-collected urine samples and vaginal samples for HPV detection as the “Paper of the week”. Another example of how IARC – International Agency for Research on Cancer / World Health Organization led studies address issues that are globally relevant and promote equity in cancer prevention.”
Quoting International Papillomavirus Society – IPVS‘s post.
“New evidence from India suggests first-void urine HPV testing can perform comparably to vaginal self-sampling while being highly acceptable to women. These findings support urine-based HPV testing as a feasible option for expanding cervical cancer screening in resource-limited settings.
Manuscript Highlights
- A community-based study in Eastern India enrolled 2500 women aged 30-60 years from multiple rural clinics.
- First-void urine showed high agreement with self-collected vaginal samples for high-risk HPV detection.
- Urine sampling had comparable CIN2+ detection and greater acceptability, supporting feasible HPV screening in resource-limited settings.”
Title: Comparative efficacy, feasibility and acceptability of HPV DNA testing on first-void urine versus self-collected vaginal samples: a real-world study in a resource-limited setting
Authors: Sreeya Bose, Ranajit Mandal, Sankar Sengupta, Sankhadeep Dutta, Priya Abraham, Richard Muwonge, Eric Lucas, Chinmay Kumar Panda, Sathishrajaa Palaniraja, Mary Luz Rol, Jayanta Chakrabarti, Partha Basu
Other articles about HPV detection on OncoDaily.